TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT02584829

Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.
“Terminated due to loss in funding”

The sponsor’s own words in the registry.

Life of this trial

201520162017201820192020202120222023Registered2015-10-21Started2015-11-06Stopped2018-12-18Results posted2022-03-22

Vital statistics

Status
Terminated
Phase
Phase 1, Phase 2
Sponsor
Fred Hutchinson Cancer Center
Sponsor type
University, hospital or other
Conditions
Merkel Cell Polyomavirus Infection; Stage IV Merkel Cell Carcinoma AJCC v7
Interventions
Avelumab; Laboratory Biomarker Analysis; MCPyV TAg-specific Polyclonal Autologous CD8-positive T Cells; Radiation Therapy; Recombinant Interferon Beta
Participants
8
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.